KERYX BIOPHARMACEUTICALS INC's ticker is KERX and the CUSIP is 492515101. A total of 126 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is 1.12 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $388,000 | -67.2% | 83,386 | -50.0% | 0.01% | -43.5% |
| Q3 2017 | $1,184,000 | +245.2% | 166,772 | +385.1% | 0.02% | +9.5% |
| Q2 2015 | $343,000 | -68.1% | 34,380 | -59.3% | 0.02% | -74.7% |
| Q1 2015 | $1,074,000 | -62.0% | 84,380 | -57.8% | 0.08% | -65.0% |
| Q4 2014 | $2,830,000 | +2.9% | 200,000 | 0.0% | 0.24% | -19.7% |
| Q3 2014 | $2,750,000 | -41.3% | 200,000 | -27.3% | 0.30% | -40.0% |
| Q1 2014 | $4,686,000 | +16.1% | 275,000 | -31.2% | 0.49% | +196.4% |
| Q3 2013 | $4,036,000 | +979.1% | 400,000 | +700.0% | 0.17% | +336.8% |
| Q2 2013 | $374,000 | – | 50,000 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management I, LLC | 1,312,006 | $22,357,000 | 15.70% |
| VHCP Management, LLC | 1,000,273 | $17,045,000 | 8.86% |
| HARVEY CAPITAL MANAGEMENT INC | 915,800 | $15,605,000 | 6.22% |
| Baupost Group | 6,310,850 | $107,537,000 | 2.60% |
| SECTORAL ASSET MANAGEMENT INC | 3,537,590 | $60,281,000 | 2.48% |
| INSIGHT CAPITAL RESEARCH & MANAGEMENT INC | 587,504 | $10,011,000 | 2.31% |
| Knoll Capital Management, LLC | 200,000 | $3,408,000 | 1.76% |
| Camber Capital Management LP | 1,250,000 | $21,300,000 | 1.67% |
| NORTHPOINTE CAPITAL LLC | 877,875 | $14,958,000 | 1.52% |
| DAFNA Capital Management LLC | 100,000 | $1,704,000 | 1.46% |